| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 29, 2007
From the Donald W. Reynolds Cardiovascular Clinical Research Center and Fondation Leducq Transatlantic Network on Atherothrombosis (F.S., G.K.S., M.A., J.C., N.G., S.-M.T.T., G.-P.S., P.L.), Brigham and Women's Hospital, Harvard Medical School, Boston, Mass; Service de Chirurgie Vasculaire (F.S.), Hôpital Henri Mondor, Créteil, France; Department of Biomedical Engineering (S.S.A.), Lerner Research Institute Cleveland Clinic, Cleveland, Ohio; and Center for Molecular Medicine (N.G.), Karolinska Institute, Stockholm, Sweden. * To whom correspondence should be addressed. E-mail: plibby{at}rics.bwh.harvard.edu.
Background—Interstitial collagen plays a crucial structural role in arteries. Although in vitro results suggest collagenase activity for membrane-bound matrix metalloproteinase type 1 (MMP-14), in vivo evidence for such a function in atherosclerosis remains scant. Methods and Results—Because Mmp14-/- mice die by 3 weeks of age, this study used lethally irradiated low-density lipoprotein receptor–deficient mice reconstituted with syngeneic bone marrow cells of Mmp14-/- or Mmp14+/+ mice. In both groups, histological analyses of the aortic root revealed similar plaque size and macrophage and smooth muscle cell content after 8 or 16 weeks of atherogenic diet. By 16 weeks, however, the plaques of low-density lipoprotein receptor–deficient mice engrafted with Mmp14-/- bone marrow (n=12) contained significantly more interstitial collagen than those receiving Mmp14+/+ bone marrow (n=14; P<0.05). In vitro, bone marrow–derived macrophages from Mmp14-/- mice had significantly less interstitial collagenase activity than those from Mmp14+/+ mice both basally (P<0.01) and on tumor necrosis factor- Conclusion—MMP-14 from bone marrow–derived cells can influence the collagen content of mouse atheroma, a critical component of plaque stability.
Accepted on November 27, 2007
Matrix Metalloproteinase-14 Deficiency in Bone Marrow–Derived Cells Promotes Collagen Accumulation in Mouse Atherosclerotic Plaques
Fabrice Schneider MD,
stimulation (P<0.05). Western blot analysis and gelatin zymography of aortic extracts revealed that MMP-14 deficiency yielded decreased activation of pro–MMP-13 but not of pro–MMP-2 or pro–MMP-8.
Related Article:
Circulation 2008 117: 857-859.
This article has been cited by other articles:
![]() |
R. C. Laxton, Y. Hu, J. Duchene, F. Zhang, Z. Zhang, K.-Y. Leung, Q. Xiao, R. S. Scotland, C. P. Hodgkinson, K. Smith, et al. A Role of Matrix Metalloproteinase-8 in Atherosclerosis Circ. Res., October 23, 2009; 105(9): 921 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sugimoto, T. Ishibashi, T. Sawamura, N. Inoue, M. Kamioka, H. Uekita, H. Ohkawara, T. Sakamoto, N. Sakamoto, Y. Okamoto, et al. LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells Cardiovasc Res, October 1, 2009; 84(1): 127 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sakamoto and M. Seiki Cytoplasmic tail of MT1-MMP regulates macrophage motility independently from its protease activity Genes Cells, May 1, 2009; 14(5): 617 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Libby Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis J. Lipid Res., April 1, 2009; 50(Supplement): S352 - S357. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xiong, R. Knispel, J. MacTaggart, T. C. Greiner, S. J. Weiss, and B. T. Baxter Membrane-type 1 Matrix Metalloproteinase Regulates Macrophage-dependent Elastolytic Activity and Aneurysm Formation in Vivo J. Biol. Chem., January 16, 2009; 284(3): 1765 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lehti, N. F. Rose, S. Valavaara, S. J. Weiss, and J. Keski-Oja MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing J. Cell Sci., January 1, 2009; 122(1): 126 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Johnson, G. B. Sala-Newby, Y. Ismail, C. M. Aguilera, and A. C. Newby Low Tissue Inhibitor of Metalloproteinases 3 and High Matrix Metalloproteinase 14 Levels Defines a Subpopulation of Highly Invasive Foam-Cell Macrophages Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1647 - 1653. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shimokawa Bone Marrow-Derived Matrix Metalloproteinase-14: A Novel Target for Plaque Stability Circulation, February 19, 2008; 117(7): 863 - 865. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |